Streetbeat News

Products Services

RPTX

Repare Therapeutics Inc. (NASDAQ:RPTX) has dosed the first patient in the camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:09 am

CRML

Critical Metals Corp. (NASDAQ:CRML) has signed a binding heads of agreement to acquire a controlling interest in the Tanbreez Greenland Rare Earth Mine from Rimbal Pty Ltd. The transaction is valued at up to $211 million and positions Critical Metals Corp. as a key supplier of rare earth elements for the western world.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:07 am

PERI

Perion Network has updated its Q2 2024 financial guidance due to changes in Microsoft Bing advertising pricing and a decline in revenue from standard video and display formats.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:05 am

CLDI

SIGA

Calidi Biotherapeutics (NYSE:CLDI) has entered into a collaboration with SIGA Technologies (NASDAQ:SIGA) to develop Calidi's RTNova virotherapy platform for lung cancer and metastatic solid tumors. The collaboration will leverage SIGA's TPOXX antiviral agent to manage RTNova's spread in vivo.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:05 am

SRDX

Surmodics has secured a group purchasing agreement with Premier, Inc. for its Pounce and Pounce Venous Thrombectomy Systems, effective June 1, 2024. This agreement allows Premier members to access special pricing and terms for these products.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:02 am

IPA

ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) announced the release of its subsidiary BioStrand's LENSai API software for AI-driven drug discovery. The software integrates with electronic health records and large language models, enabling enhanced research and drug discovery capabilities. A full data management platform is expected in Q1/Q2 2025.

Portfolio Pulse from Vandana Singh

June 10, 2024 | 11:01 am

IPA

ImmunoPrecise Antibodies' subsidiary, BioStrand, has announced the immediate commercial offering of its software with a customizable interface for AI-driven drug discovery.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 11:00 am

SGC

Safe and Green Development Corporation (SGC) has acquired the AI technology MyVONIA for up to 500,000 shares of its common stock. The acquisition includes a non-compete agreement with Dr. Axely Congress, who will also continue to develop MyVONIA under a consulting agreement.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 10:55 am

IYW

MSFT

SONY

XLK

Microsoft's Xbox Division unveiled new all-digital Xbox Series X and S consoles and trailers for over a dozen upcoming games at the Xbox Games Showcase. The company aims to boost console sales amid declining gaming industry revenues and layoffs. Key highlights include a disc-less Series X and S, a special edition Series X with 2TB storage, and new game titles like 'Doom: The Dark Ages' and a 'Gears of War' sequel. Microsoft focuses on Xbox Game Pass to attract consumers by offering major titles at launch. Microsoft stock has gained over 27% in the last 12 months.

Portfolio Pulse from Shivani Kumaresan

June 10, 2024 | 10:28 am

NVDA

Nvidia Corp. (NASDAQ:NVDA) has been a top performer in the S&P 500, driven by its leadership in AI technology. The company's Data Center business, which now accounts for 87% of its revenue, has seen a 427% year-over-year growth. Nvidia's stock has surged 730% since the start of 2023 and 144% this year. A $1,000 investment in Nvidia in 2008 would be worth $260,631.68 today, reflecting a 25,963.17% return.

Portfolio Pulse from Shanthi Rexaline

June 10, 2024 | 10:11 am